TOKYO--(BUSINESS WIRE)--Sosei Group Corporation (“Sosei”)(TOKYO:4565) confirms that Novartis Pharma K.K. launched once-daily Ultibro ® Inhalation Capsules (“Ultibro ® ”; glycopyrronium / indacaterol), ...
Novartis and UK group Vectura will be celebrating news that regulators in Europe and Japan have issued green lights for the dual bronchodilator Ultibro Breezhaler for the treatment of COPD, a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results